Abstract
Background: Sickle Cell Disease (SCD) is a hereditary blood disorder that significantly affects African American urban communities in the United States. This study examines the residential context of individuals with SCD in New York City (NYC), exploring how cardiopulmonary symptoms relate to the proximity to the healthcare center and accessible and non-accessible public transit. Methods: This cross-sectional study was conducted by geocoding addresses of 80 patients (≥18 years) with confirmed SCD in NYC, collected from January to December 2019. Questionnaires recorded symptoms of fatigue and dyspnea severity (rated on a 0 (none)-10 (worst) Likert scale) prior to (baseline) and after (end) completing a 6-minute walk test. Data were stratified by NYC borough. MTA Subway Accessible Station Platform Availability access was extracted from NYOpen Data. Geospatial analysis was conducted in QGIS LTR 3.40.9 by computing linear distance to transit (subway lines, accessible subway stations with elevators) and to the care center from participant addresses. Preliminary descriptive statistics were calculated. Results: Participants identified as female (n = 43, 54%), male (n = 36, 46%), with mean age of 33 (SD = 10.2). Participants identified as Black or African American (n = 66, 81%), Hispanic or Latino (n = 17, 21%), and Other (n = 3, 4%). Mean baseline dyspnea was 0.48 (SD = 0.82) and mean end dyspnea was 1.31 (SD = 1.36). Mean baseline fatigue was mean = 1.07 (SD = 1.44) and mean end fatigue was 1.39 (SD = 1.55). Mean linear distance to the closest subway line was 2.37 miles (SD = 8.79). Mean linear distance to accessible subway stations was 2.65 miles (SD = 9.76). Mean linear distance to the care center was 7.58 miles (SD = 11.07). Conclusions: Patients exhibited increased fatigue and dyspnea after the 6-minute walk test. They reside relatively far from subway lines and accessible subway stations. Future studies should investigate whether transit accessibility influences symptom burden in the SCD population.